Author: World Health OrganizationPublisher:
ISBN:
Category : Drug utilization
Languages : en
Pages : 87
Book Description
How to Investigate Drug Use in Health Facilities: Selected Drug Use Indication Action Programme on Essential Drugs
Author: World Health OrganizationPublisher:
ISBN:
Category : Drug utilization
Languages : en
Pages : 87
Book Description
How to investigate drug use in health facilities
Author: How to investigate drug use in health facilities
Author: How to Investigate Drug Use in Health Facilities
Author: Publisher:
ISBN: 9780119514995
Category : Allied health personnel
Languages : en
Pages : 87
Book Description
The Selection and Use of Essential Medicines
Author: WHO Expert Committee on the Selection and Use of Essential MedicinesPublisher: WHO
ISBN:
Category : Medical
Languages : en
Pages : 144
Book Description
This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a progress report on the new procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues with a section on changes made in revising the Model List followed by a review of some sections such as hypertensive medicines and fast track procedures for deleting items. Annexes include the 13th version of the Model List and items on the list sorted according to their 5-level Anatomical Therapeutic Chemical classification codes.
Preventing HIV Transmission
Author: National Research Council and Institute of MedicinePublisher: National Academies Press
ISBN: 0309176212
Category : Medical
Languages : en
Pages : 352
Book Description
This volume addresses the interface of two major national problems: the epidemic of HIV-AIDS and the widespread use of illegal injection drugs. Should communities have the option of giving drug users sterile needles or bleach for cleaning needs in order to reduce the spread of HIV? Does needle distribution worsen the drug problem, as opponents of such programs argue? Do they reduce the spread of other serious diseases, such as hepatitis? Do they result in more used needles being carelessly discarded in the community? The panel takes a critical look at the available data on needle exchange and bleach distribution programs, reaches conclusions about their efficacy, and offers concrete recommendations for public policy to reduce the spread of HIV/AIDS. The book includes current knowledge about the epidemiologies of HIV/AIDS and injection drug use; characteristics of needle exchange and bleach distribution programs and views on those programs from diverse community groups; and a discussion of laws designed to control possession of needles, their impact on needle sharing among injection drug users, and their implications for needle exchange programs.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Registries for Evaluating Patient Outcomes
Author: Agency for Healthcare Research and Quality/AHRQPublisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385
Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Understanding and Responding to Drug Use
Author: Jane FountainPublisher:
ISBN:
Category : Medical
Languages : en
Pages : 364
Book Description
This monograph is the product of the decision of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to launch a project in 1996 to obtain a comprehensive overview of qualitative research on drugs in Europe. The opening section highlights the multiple roles of qualitative research in understanding and responding to drug use. Part II addresses the impact of qualitative research on policy-making. Part III provides examples of research conducted in European Union cities that has been specifically designed to identify and verify new trends in drug use. Part IV on risk behaviour demonstrates how qualitative research methods have made a considerable contribution to the knowledge and understanding of health risks associated with drug injecting. Subsequent sections consider the theme of social exclusion, drug markets, and drug services evaluation. The final section is given over to qualitative research on drug use within a global research agenda. It reveals the scale of qualitative drug research varies greatly between countries, that little is published in the drug-specific scientific journals and that high quality work often appears to fail to influence policy. The monograph concludes that a comprehensive approach should include the training of individual experts and research teams and exchanges of experience between researchers across and beyond Europe.
How to Investigate Drug Use in Communities
Author: Anita HardonPublisher:
ISBN:
Category : Drug utilization
Languages : en
Pages : 43
Book Description